Table 2.
Presenting symptoms in cases (cSAH) and controls
| cSAH (n = 19) | Controls (n = 76) | Confirmed TIA subgroup (n = 30) | p value* | Univariable OR** (95% CI) | |
|---|---|---|---|---|---|
| Migratory (spreading) symptoms | 6 (32) | 2 (3) | 0 (0) | 0.001 | 17.3 (3.1–93.9) |
| Sensory disturbance | 9 (47) | 11 (14) | 2 (7) | 0.003 | 5.3 (1.8–16.0) |
| Recurrent stereotyped events | 9 (47) | 15 (19) | 4 (13) | 0.02 | 3.7 (1.3–10.6) |
| Paraesthesia | 3 (16) | 4 (5) | 1 (3) | 0.1 | 3.3 (0.7–16.6) |
| Cheiro-oral symptoms | 2 (11) | 0 (0) | 0 (0) | 0.4 | 2.1 (0.4–12.5) |
| Weakness | 7 (37) | 22 (29) | 13 | 0.5 | 1.4 (0.5–4.1) |
| Speech disturbance | 5 (26) | 19 (25) | 10 (33) | 0.9 | 1.3 (0.3–3.4) |
| Visual disturbance | 0 (0) | 19 (25) | 5 (17) | 0.08 | 0.08 (0.004–1.3) |
*Difference in proportions for cSAH vs controls
**For cSAH vs controls